Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
- Citation:
- N Engl J Med vol 379 (2) 122-37
- Year:
- 2018
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Pharmas:
- Grants:
- U10CA075362; BCRF- 16-185; Zealand- 351161, 510788, 1105058; ICR-CTSU- CRUKE/03/022, CRUKE/03/023, A15955; U10CA180821; SWOG- U10CA32102; EA- U10CA21115, U10CA16116; NRG- U10CA12027, U10CA69651, U10CA37377, U10CA69974;CCTG - U10CA077202; CCSR 01546, 021039
- Corr. Author:
- Authors:
- P. A. Francis O. Pagani G. F. Fleming B. A. Walley M. Colleoni I. Láng H. L. Gómez C. Tondini E. Ciruelos H. J. Burstein H. R. Bonnefoi M. Bellet S. Martino C. E. Geyer Jr M. P. Goetz V. Stearns G. Pinotti F. Puglisi S. Spazzapan M. A Climent L. Pavesi T. Ruhstaller N. E. Davidson R. Coleman M. Debled S. Buchholz J. N. Ingle E. P. Winer R. Maibach M. Rabaglio‑Poretti B. Ruepp A. Di Leo A. S. Coates R. D. Gelber A. Goldhirsch M.M. Regan
- Networks:
- LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-PA015, NY018, OH070, UPSTATE
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- IBCSG-24-02 (SOFT-TEXT), IBCSG-25-02 (TEXT), SWOG-S0002
- Phases:
- 3
- Keywords: